HPV and Cancer: A Closer Look at Their Linkage

Have you ever come across a virus that can initiate a highly dangerous form of cancer, potentially resulting in fatal outcomes in severe cases? Thus far, the most feared viruses that people are familiar with are undoubtedly the coronavirus and, to a lesser extent, HIV. However, another virus which is far more dreadful is Human papilloma Virus.

HPV or Human Papilloma Virus is an ever increasing but still an unknown collection of viruses that has far-reaching consequences. If left untreated and undetected, it can cause different types of cancer including cancers of cervix, vagina, and vulva in women, penis in males, anal in both men and women, back of the throat including base of the tongue and tonsils (oropharynx), in both males and females.

In this post, we will try to deep dive into learning more about HPV through some facts and common questions encountered and how it can be prevented. Our aim here is to make our readers more aware about the ill effects of this virus and that it can be as scary as death. It’s our little effort to spread a word as they say, “half knowledge is better than no knowledge.”

The Basics

HPV is a group of viruses of more than 200 varieties, which can be arranged into two categories: low risk and high risk. Low-risk strains habitually do not lead to illnesses, yet they can generate warts on or around the genitals, rectum, or windpipe. In contrast, high-risk HPVs have the potential to cause more severe health consequences, counting cancer. Specifically, HPV16 and HPV18 are mainly responsible for HPV-linked malignancies. Almost all sexually active individuals acquire HPV within a few years of their sexual debut. Surprisingly, nearly half of these infections are high-risk HPV strains. It’s essential to recognize that HPV is indiscriminate—it doesn’t differentiate between sex, gender identity, or sexual orientation. Everyone can be affected by its hidden presence. Under regular conditions, the immune system acts as a protector against HPV infections, keeping them under control and halting any significant harm. This is why most of the high-risk HPV infections don’t progress to cancer; the protective immune system is typically capable of containing them. Nevertheless, in certain cases, high-risk HPV infections outwit the immune system and bring about molecular alterations, which, if left unattended, may bring about cancer.

HPV Associated Cancers and How does it spread?

HPV doesn’t just cause warts; it can also lead to various types of cancers. These cancers can develop in areas where HPV infects cells, like the genital region, throat (back of the throat), anus, organs, vagina, and vulva. While cervical cancer is strongly linked to HPV, regular screenings play a crucial role in preventing it. Additionally, HPV significantly increases the risk of pharyngeal cancers, anal cancer, penile cancer, vaginal cancer, and vulval cancer.

HPV is highly contagious and spreads easily through different forms of skin-to-skin contact, especially during intimate moments. This includes sexual activities like vaginal-penile intercourse, penile-anal intercourse, penile-oral intercourse, vaginal-oral intercourse, and even the use of sex toys or other objects. While using condoms and dental dams can lower the risk, they don’t provide complete protection against HPV.

The seriousness of high-risk HPV infections is notable because they often don’t show symptoms. Many people carrying the high-risk HPV strain are unaware of the infection in their bodies. This sneaky virus can lead to precancerous changes in certain areas, often without noticeable signs, underscoring the importance of regular cancer screenings. Sometimes, these precancerous lesions can cause itching and bleeding. On the flip side, more advanced stages of HPV may show signs similar to cancer, such as bleeding, pain, or swollen glands.

HPV becomes problematic when it infiltrates cells, disrupting their communication and causing uncontrolled cell growth—a process the immune system normally regulates. If the virus persists, it can lead to the formation of precancerous cells. If not treated, these cells can eventually transform into cancerous cells, a process that may take a decade or more. Persistent HPV infection can be influenced by factors ranging from the severity of the virus strain to the carrier’s lifestyle, such as smoking or a weakened immune system.

How can we prevent the infection?

Through Vaccination…yes, vaccination can help prevent this infection thereby reducing your chances to get the deadly cancer. Getting the HPV vaccine is incredibly important. It’s recommended for both girls and boys, and it’s best to start around the age of 11 or 12, though it can begin as early as 9. This vaccine is crucial for everyone because HPV can cause different cancers and genital warts in both boys and girls. The vaccine works best when you start before, you’re 15, and you’ll need two doses to be fully protected. If you begin the series later, up to age 26, three doses are recommended for the best protection.
For people between 27 and 45 who haven’t finished their HPV shots, getting vaccinated is still an option, but it might not work effectively.

As you get older, you’re more likely to have come across HPV already. Once a person gets HPV, the vaccine may not be as effective. That’s because the vaccine’s goal is to prevent new infections. If a person has the virus, the vaccine may not help the body clear out the vaccine.

So, normally, getting vaccinated isn’t something everyone in this age group does routinely. But if you’re worried about the chance of getting new HPV infections, it’s a good idea to talk to your doctor. They can help figure out if getting vaccinated is the right move for you.

Does the HPV vaccine offer benefits if you’re already sexually active?

People who are sexually active should talk with their healthcare team about the benefits of getting an HPV vaccine.
Most people catch HPV soon after they become sexually active. But even if you have one strain of HPV, you might still benefit from the vaccine. It can protect you from other strains that you don’t yet have.
But none of the vaccines can treat an existing HPV infection. The vaccines protect you only from specific strains of HPV you don’t have.

Is screening required even after getting vaccinated?

A big yes!!! The HPV vaccine doesn’t replace Pap tests. Screening for cervical cancer with regular Pap tests starting at age 21 is an essential part of preventive healthcare.
Get medical attention right away if you notice any symptoms of cervical cancer. Some symptoms are vaginal bleeding after sex, between periods or after menopause; pelvic pain; or pain during sex.

In the fight against HPV and its serious health dangers, education and awareness are our main tools for defense. Knowing how common HPV is, understanding its subtle symptoms, and recognizing the crucial role of vaccination empowers each person to be in control of their health. By spreading this information in a way that everyone can understand, we can all work together to keep our community healthy and strive to get rid of this hidden but powerful threat. Awareness is like our protective gear, and getting vaccinated is our shield against the sneaky enemy that is HPV.

About Author

Akanksha Nagar is an intern with CAPED India and is currently pursuing MBA from SOIL Institute of Management.



He initiated TQM as a management way in SRF and the Company has so far earned the Deming Prize for two of its businesses, for the tyre cord in 2004 and for the Chemicals Business in 2012.

Mr. Bharat Ram was elected President of Confederation of Indian Industry (CII) during 2000-2001 and continued to play important roles as Chair and Member of various council of CII till March 2015. He co-chaired the Indo German Consultative Group (IGCG) which consisted of eminent citizens from both the countries from 2002 till 2014.

Mr. Bharat Ram is actively involved in social development activities. Currently he is Chairman of:

  • SRF Foundation, the social wing of SRF, which manages its own schools and also supports education in villages;
  • The Lady Shri Ram College (LSR) for Women in Delhi which has consistently been rated as one of the two best colleges of India;
  • The Shri Ram Schools; and
  • CAF (India) – Charities Aid Foundation (India); and
  • A governing body member of CAPED– a registered Society for spreading cancer awareness program

He is on the governing body of SPIC Macay, a society for the promotion of the Indian Classical Music. He is himself an accomplished sitar player, having learnt it from Pt. Ravi Shanker.

Mr. Arun Bharat Ram has won many awards and accolades, The Jamshedji Tata Award, which was conferred on him by the Indian Society for Quality (ISQ) for the year 2006 and the Officer’s Cross of the Order of Merit, presented by the Federal Government of Germany in 2008. Mr. Bharat Ram schooled at the Doon School, Dehra Dun and graduated in Industrial Engineering from the University of Michigan, U.S.A.

Prior to his current appointment, Dr. Vaid practiced and coordinated the Department of Medical Oncology at the Rajiv Gandhi Cancer Institute and Research Centre (RGCI) in Rohini, Delhi, India. In addition to his active medical oncology practice, Dr. Vaid has participated in many national and international clinical trials as a principal and sub-investigator. His clinical interests include Hemato-Oncology and Bone Marrow Transplant. He has also taken keen interest in treating breast cancer, lung cancer and genitor-urinary cancers.

Dr. Vaid established the bone marrow transplant services in the private sector in Delhi starting with Rajiv Gandhi Cancer Institute & Research Centre during the last decade and has cumulatively carried out the largest number of bone marrow transplants in the private sector in Delhi. Currently at Medanta, he leads a large team which comprises of hemato-oncologists, pediatric transplant specialists, hemato pathologists specializing in transplant pathology, transfusion specialists, and molecular pathologists required for HLA typing and post transplant chimerism monitoring.

Dr. Vaid lectures nationally and internationally and has contributed to numerous peer-reviewed articles, book chapters and abstracts. His work has appeared in Journal of Clinical Oncology, Journal of Thoracic Oncology, World Journal of Gastroenterology and Hepatobiliary Pancreatic Diseases International. Dr. Vaid currently chairs the Indian Council of Medical Research Subcommittee on formulating guidelines for treatment of Hodgkin’s Disease in India. He is recognized as Teacher and Examiner for superspeciality course of Medical Oncology by National Board of Examinations and the Bombay University and a reviewer of thesis for award of PhD degree in Life Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, India. He is an editorial board member for the following journals “Research & Reviews: A Journal of Medicine” and “Research & Reviews: A Journal of Toxicology”, and “South Asian Journal of Cancer”.

He was conferred the prestigious “Padma Shree” Award, one of the highest civilian award in India, by the President of India in 2009 for his contribution to the field of medicine on 14th April, 2009.
Prior to Stellaris, Alok was a Partner at another VC firm, Helion Ventures, where he led enterprise software and services investments. Before his career in venture capital, Alok was the Chief Operating Officer (COO) of SAP India and had been associated with SAP since the year 2004 in various leadership roles in the United States and in India. Before SAP, Alok also worked with Siebel Systems, The McKenna Group, McKinsey & Company and Cadence Design Systems.

Alok has completed his MBA from INSEAD (France), MS in Computer Sciences from University of Texas, Austin and his B.Tech in Computer Science from IIT Delhi.

Alok is interested in cricket, light & classical Indian music, hiking and long distance running. In addition, Alok is passionate about mathematical puzzles and used to run a weekly blog at http://alokgoyal1971.com/.

Alok’s association with cancer started in 2007 when his mother was diagnosed with a late stage Ovarian Cancer. He saw his mother battle with cancer for more than four years, during which time he was the primary care giver.

Committees / Ambassador Radhika is a part of many committees in CII and is also Pinkathon Ambassador. Social Initiatives

  • Radhika has participated in plays as a lead singer to raise funds for NGO’s like Azad Foundation and CAPED.
  • Mamma Mia Again, ABBA songs Musical, was staged at The Shri Ram Center, Delhi in December 2016 to raise funds for Azad Foundation.
  • I have a Dream, ABBA songs Musical, was staged at Apparel House, Gurgaon to raise funds for CAPED in April 2017.
  • I have a Dream, ABBA songs Musical, was staged at The Shri Ram Center, Delhi to raise funds for CAPED in December 2017.
  • She was also instrumental in staging a play, Khushi Ek Ehsaas, by the visually impaired children of JPM School to raise funds for Blind Relief Association at Kamani Auditorium in January 2016.

Hobbies

  • Radhika learns music at Theme.
  • She also loves to run and has completed 3 half Marathons in India in 2017.

Amitav worked for Bristol Myers Squibb based in Princeton for 5 years. He has been involved with his family-run business since 1994.

Amitav was educated at the Doon School and went on to study Economics at St. Stephens College, Delhi University. He has an MBA from UNC Chapel Hill, USA. He sits on the board of Central Square Foundation, AVPN India and several other non/for-profit organisations in India.

In 2010, he became an Aspen Fellow, in 2015 he became an Ashoka Fellow and 2017 he was incubated as an N/Core Fellow.

Organizational Positions
  • Vice President, Fertility Preservation society of India/ 2014 – 2018
  • Coordinator, Deptt of Obstetrics and Gynaecology, Artemis Hospital, Gurgaon, April 2007 – Nov 2009
  • Coordinator, (North India), Clinical Research Committee, Federation of Obstetrics & Gynecology Society of India (FOGSI) 2003-2008
  • Executive Member, Adolescent committee, Association of Obstetrics & Gynaecologists of Delhi (AOGD ) 2006 – 2007
  • Executive Member, Association of Gynaecologic Oncologist of India,2009 -2011
  • Chairperson, Gynaec. Oncology Committee, Gurgaon Obstetrics and Gynaecology Society, 2011
  • Executive Member, Gynaec.Oncology Committee, Association of Obstetrician & Gynaecologists of Delhi (AOGD) 2012 -2014
  • Executive Member, Gurgaon Obstetrics and Gynaecology Society (GOGS), 2012 -2013
  • Coordinator – Young Women Club ( National Project under the aegis of National Adolescent Health Committee, FOGSI) 2012 -2013
  • Treasurer, Asia Oceania Research Organization in Genital infections and Neoplasia ( AOGIN) –India, 2011 -2015
  • Executive member, Gynaec Oncology Committee, Federation of Obstetrics & Gynecology Society of India (FOGSI).2012 -2015
  • Peer Reviewer for the Journal of Federation of Obstetrics & Gynecology Society of India (FOGSI).
  • Peer Reviewer for The Indian Journal of Gynaecologic Oncology.
  • Invited as a trainer by Vattikuti Foundation, Michigan, USA for – Gynaec. Robotic Surgery Training of Gynaecologists at KIMS Vattikuti Institute of Robotic Surgery, Hyderabad
  • Executive member, AOGD(Association of Obsterician and Gynaecologist of Delhi ) 2013 – 2014
  • Executive member, AOGD(Association of Obsterician and Gynaecologist of Delhi ) 2014-2015
  • Executive member,GOGS 2013
  • Executive member, Gynaec.Oncology Committee, Association of Obstetrician & Gynaecologists of Delhi (AOGD) 2013 -2014
  • Executive member, Gynaec.Endoscopy Committee, Association of Obstetrician & Gynaecologists of Delhi (AOGD) 2013 -2014
  • Executive member, International academic exchange committee(FOGSI) 2013 – 2015
  • Executive member, Delhi Society of Gynaec endoscopists.2014- 2015
  • Co-Chairperson, Gynaec.Oncology Committee, Association of Obstetrician & Gynaecologists of Delhi (AOGD) 2015 -2016
  • Executive member, Gynaec Oncology Committee, Federation of Obstetrics & Gynecology Society of India (FOGSI).2015 -2017